Breaking News Instant updates and real-time market news.

MRVL

Marvell

$24.37

0.03 (0.12%)

, CAVM

Cavium

$90.95

-0.04 (-0.04%)

08:43
03/13/18
03/13
08:43
03/13/18
08:43

Marvell-Cavium deal in focus after denial of Broadcom-Qualcomm, says Benchmark

After President Trump signed an order prohibiting Broadcom's (AVGO) attempt to take over Qualcomm (QCOM), Benchmark analyst Gary Mobley said the news may cause investors to question CFIUS approval for the planned tie-up of Marvell (MRVL) with Cavium (CAVM). It is possible Marvell may have to re-domicile in the U.S. from Bermuda, which may delay the merger by a few months and would increase Marvell's tax rate unfavorably, he said. Mobley, who think it is hard to say whether the President will shoot down the deal, noted that CFIUS and China's MOFCOM are the last two regulatory hurdles for Marvell and Cavium's deal. He has a Buy rating on Marvell shares.

MRVL

Marvell

$24.37

0.03 (0.12%)

CAVM

Cavium

$90.95

-0.04 (-0.04%)

QCOM

Qualcomm

$62.81

-0.22 (-0.35%)

AVGO

Broadcom

$262.84

9.06 (3.57%)

  • 15

    Mar

  • 15

    Mar

  • 16

    Mar

  • 29

    Mar

MRVL Marvell
$24.37

0.03 (0.12%)

03/12/18
ARGS
03/12/18
NO CHANGE
Target $28
ARGS
Buy
Marvell remains undervalued on cash flow growth prospects, says Argus
Argus analyst Jim Kelleher keeps his Buy rating and a $28 price target on Marvell, writing the company has improved its execution through focus on value-added opportunities. The analyst also believes that while the stock price has moved higher, Marvell's valuation remains attractive relative to that of peers and considering the company's cash flow growth potential.
03/12/18
NEED
03/12/18
NO CHANGE
Target $27
NEED
Buy
Marvell growth across core businesses is encouraging, says Needham
Needham analyst N. Quinn Bolton keeps his Buy rating and $27 price target on Marvell (MRVL) after the company's "slightly above expectations" Q4 results and above-consensus Q1 outlook. Bolton says the Q4 report suggests "traction in new enterprise and data center products and strength in the SSD controller family", while modest sequential revenue growth in Networking and the progressing accretive Cavium (CAVM) acquisition with cost synergies of up to $175M add to his bullish view.
03/09/18
COWN
03/09/18
NO CHANGE
Target $29
COWN
Outperform
Marvell price target raised to $29 from $21 at Cowen
Cowen analyst Karl Ackerman raised his price target on Marvell (MRVL) to $29 from $21 citing its acquisition of Cavium (CAVM). He also contends its organic growth rate is misleading, as it includes several businesses that have been sold and sees storage headwind concerns as overblown. Ackerman reiterated his Outperform rating on Marvell shares.
03/09/18
OPCO
03/09/18
NO CHANGE
Target $30
OPCO
Outperform
Oppenheimer a buyer of Marvell shares after latest beat/raise results
Oppenheimer analyst Rick Schafer reiterated his Outperform rating on Marvell Technology following the company's beat and raise quarter. In a research note to investors, Schafer said Marvell's core business growth of about 8% year over year and gross margin expansion shows the structural improvements the company's new management has brought in just 18 months, adding that the planned growth and margin accretive Cavium acquisition "only serves to amplify these trends." "We are buyers here," Schafer added, noting that he has a $30 price target on shares.
CAVM Cavium
$90.95

-0.04 (-0.04%)

03/07/18
KEYB
03/07/18
NO CHANGE
KEYB
KeyBanc remains a buyer of Intel, Marvell
In a research note titled "Notebook ODM tracker," KeyBanc analyst Michael McConnell says February unit shipments are likely to be modestly below his estimates, but is maintaining his Q1 unit shipment estimate of -18% quarter over quarter. McConnell remains a buyer of Intel (INTC) due to its processor sell-in, and signs of improving commercial demand. The analyst also remains constructive on Marvell (MRVL) due to higher confidence on revenue growth, driven by the networking and SSD controller segments, design-win traction and sales momentum into data centers, and higher networking and data center sales mix, gross margin accretion, and multiple expansion from the pending Cavium (CAVM) acquisition.
03/07/18
ARGS
03/07/18
INITIATION
Target $28
ARGS
Buy
Marvell initiated with a Buy at Argus
Argus analyst Jim Kelleher initiated Marvell (MRVL) with a Buy rating and a price target of $28. Kelleher expects the company's total addressable market to double after its acquisition of Cavium (CAVM), as the deal will provide marvell with an entry into "complementary product markets". The analyst also foresees stabilizing margins and revenues after several years of decline for Marvell thanks to its asset portfolio reorganization and dispositions. Kelleher believes that the valuation on Marvell is attractive at current levels, with the stock trading at 19.4-times his FY18 EPS target.
QCOM Qualcomm
$62.81

-0.22 (-0.35%)

03/12/18
KEYB
03/12/18
NO CHANGE
Target $320
KEYB
Overweight
Broadcom risk/reward positive with limited downside, says KeyBanc
KeyBanc analyst John Vinh sees a positive risk/reward on shares of Broadcom (AVGO) with limited downside ahead of the company's Q1 results. At current levels, the stock has effectively priced in a very low probability of a successful acquisition of Qualcomm (QCOM), Vinh tells investors in a research note. The analyst would be opportunistic buyers of the stock. He keeps a Overweight rating on Broadcom with a $320 price target.
03/12/18
BMOC
03/12/18
NO CHANGE
Target $345
BMOC
Outperform
Broadcom price target raised to $345 from $330 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Broadcom (AVGO) to $345 citing his new FY18 EPS target of $5.10 based on the company's revised guidance in January. Srivastava keeps his Outperform rating going into the next earnings update, noting that fundamentals for Broadcom remain "strong" even as much of the investor focus is around its bid for Qualcomm (QCOM). The analyst forecasts Broadcom Wireless Communications segment to grow 10% on the quarter and Enterprise Storage segment to grow 40% on the quarter.
03/13/18
RHCO
03/13/18
NO CHANGE
Target $335
RHCO
Broadcom price target lowered to $335 from $344 at SunTrust
SunTrust analyst William Stein lowered his price target on Broadcom (AVGO) to $335 after the company's bid for Qualcomm (QCOM) came undone. Stein says the new price target is based on Broadcom's stand-alone valuation and potential accretion from another medium-sized deal, forecasting the company to pursue another target "in due time". The analyst keeps his Buy rating on Broadcom, adding that M&A has been a "massive driver" of its earnings growth.
03/13/18
ADAM
03/13/18
NO CHANGE
Target $86
ADAM
Buy
Qualcomm weakness a buying opportunity, says Canaccord
Canaccord analyst T. Michael Walkley noted the White House blocked the takeover of Qualcomm (QCOM) by Broadcom (AVGO) in the interest of national security. He expects the shares of Qualcomm to be weak as a result and recommends investors buy the shares on the pullback. He left his estimates and price target the same and believes its valuation will be compelling, especially if it closes the NXP Semiconductor (NXPI) deal. Walkley reiterated his Buy rating and $86 price target on Qualcomm shares.
AVGO Broadcom
$262.84

9.06 (3.57%)

TODAY'S FREE FLY STORIES

IFF

International Flavors

$122.54

-0.98 (-0.79%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
International Flavors rating change at Goldman Sachs »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

QRVO

Qorvo

$69.15

-0.93 (-1.33%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Qorvo rating change at Goldman Sachs »

Qorvo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

ATI

Allegheny Technologies

$26.02

0.065 (0.25%)

21:34
03/20/19
03/20
21:34
03/20/19
21:34
Upgrade
Allegheny Technologies rating change at Goldman Sachs »

Allegheny Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$4.98

0.17 (3.53%)

21:33
03/20/19
03/20
21:33
03/20/19
21:33
Upgrade
Internap rating change at Wells Fargo »

Internap upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$108.62

-1.79 (-1.62%)

, CAG

Conagra Brands

$22.91

0.095 (0.42%)

20:25
03/20/19
03/20
20:25
03/20/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$108.62

-1.79 (-1.62%)

CAG

Conagra Brands

$22.91

0.095 (0.42%)

CMC

Commercial Metals

$16.06

-0.06 (-0.37%)

GIII

G-III Apparel

$35.09

-0.475 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

HYMTF

Hyundai Motor

$0.00

(0.00%)

19:51
03/20/19
03/20
19:51
03/20/19
19:51
Periodicals
Hyundai shareholders to vote on Elliott Management dividend demand, Reuters says »

Hyundai Motor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVBF

CVB Financial

$21.12

-0.53 (-2.45%)

19:45
03/20/19
03/20
19:45
03/20/19
19:45
Hot Stocks
CVB Financial raises quarterly dividend to 18c from 14c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAMN

Kaman

$57.84

0.345 (0.60%)

19:24
03/20/19
03/20
19:24
03/20/19
19:24
Periodicals
Kaman exploring sale of distribution segment, Bloomberg says »

Kaman is looking into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

VALE

Vale

$13.49

-0.21 (-1.53%)

19:19
03/20/19
03/20
19:19
03/20/19
19:19
Hot Stocks
Vale suspends operations at Alegria mine in Mariana complex on preventive basis »

Vale S.A. informs that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

EQH

AXA Equitable

$20.84

-0.565 (-2.64%)

19:12
03/20/19
03/20
19:12
03/20/19
19:12
Syndicate
AXA Equitable 40M share Secondary priced at $20.50 »

JPMorgan, Morgan Stanley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

OTTW

Ottawa Bancorp

$13.56

-0.14 (-1.02%)

19:02
03/20/19
03/20
19:02
03/20/19
19:02
Hot Stocks
Ottawa Bancorp declares special dividend of 35c per share »

The special dividend will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$133.73

-1.74 (-1.28%)

18:57
03/20/19
03/20
18:57
03/20/19
18:57
Hot Stocks
Jazz Pharmaceuticals' Sunosi for excessive daytime sleepiness approved by FDA »

Jazz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

AYI

Acuity Brands

$123.00

-5.53 (-4.30%)

18:52
03/20/19
03/20
18:52
03/20/19
18:52
Upgrade
Acuity Brands rating change at Goldman Sachs »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

HYAC

Haymaker Acquisition

$11.79

(0.00%)

, OSW

OneSpaWorld

$0.00

(0.00%)

18:47
03/20/19
03/20
18:47
03/20/19
18:47
Hot Stocks
OneSpaWorld says will start trading on Nasdaq March 21 »

OneSpaWorld Holdings…

HYAC

Haymaker Acquisition

$11.79

(0.00%)

OSW

OneSpaWorld

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

, MU

Micron

$40.08

-0.3 (-0.74%)

18:46
03/20/19
03/20
18:46
03/20/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

MU

Micron

$40.08

-0.3 (-0.74%)

WSM

Williams-Sonoma

$56.88

0.09 (0.16%)

SIEN

Sientra

$9.76

0.945 (10.73%)

EB

Eventbrite

$20.09

-0.72 (-3.46%)

GES

Guess

$22.10

-0.41 (-1.82%)

UNIT

Uniti Group

$10.01

0.15 (1.52%)

WEX

Wex

$184.85

-1.465 (-0.79%)

CBMG

Cellular Biomedicine

$18.26

0.38 (2.13%)

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

  • 21

    Mar

  • 21

    Mar

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

18:39
03/20/19
03/20
18:39
03/20/19
18:39
Hot Stocks
Sage Therapeutics CEO: Postpartum depression is a medical issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$174.38

-1.39 (-0.79%)

18:27
03/20/19
03/20
18:27
03/20/19
18:27
Recommendations
Nvidia analyst commentary at Tigress Financial »

Nvidia to overcome…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$56.17

-0.93 (-1.63%)

18:24
03/20/19
03/20
18:24
03/20/19
18:24
Periodicals
CVS to start selling CBD products in partnership with Curaleaf, Bloomberg says »

Curaleaf (CURLF) said…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$56.17

-0.93 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

PETQ

PetIQ

$29.87

0.91 (3.14%)

18:23
03/20/19
03/20
18:23
03/20/19
18:23
Hot Stocks
PetIQ CEO: We are totally transparent about our price model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

T

AT&T

$30.51

-0.19 (-0.62%)

18:21
03/20/19
03/20
18:21
03/20/19
18:21
Periodicals
AT&T CEO: Huawei makes it hard for carriers to shift suppliers, Reuters says »

AT&T CEO Randall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 07

    May

  • 20

    May

SGSOY

SGS SA

$0.00

(0.00%)

18:19
03/20/19
03/20
18:19
03/20/19
18:19
Downgrade
SGS SA rating change at Goldman Sachs »

SGS SA downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$155.94

-0.93 (-0.59%)

, RBGLY

Reckitt Benckiser

$0.00

(0.00%)

18:16
03/20/19
03/20
18:16
03/20/19
18:16
Hot Stocks
Clorox files false advertising lawsuit against Reckitt Benckiser »

The Clorox Company (CLX)…

CLX

Clorox

$155.94

-0.93 (-0.59%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BA

Boeing

$376.41

2.54 (0.68%)

18:09
03/20/19
03/20
18:09
03/20/19
18:09
Periodicals
Boeing pushes flight test to International Space Station to August, Reuters says »

Boeing has postponed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CE

Celanese

$101.04

0.08 (0.08%)

18:02
03/20/19
03/20
18:02
03/20/19
18:02
Hot Stocks
Celanese increases acetyl intermeditates prices »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

17:58
03/20/19
03/20
17:58
03/20/19
17:58
Syndicate
Frontdoor 16.73M share Secondary priced at $30.00 »

JPMorgan and Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.